Inhibikase Therapeutics, Inc. (IKT) Institutional Ownership & Insider Trading
106 institutions reported holding Inhibikase Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 1 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IKTInhibikase Therapeutics, Inc.Follow IKT — free
—
Price chart with a free account
- Market cap
- 221.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters106 institutions held 89.1% of the shares. Across filers that reported both quarters, shares held changed +5.6%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 106 | 124 | +5.6% | 48 | 17 | 22 | 12 |
| Mar 26 | 104 | 118 | +10.7% | 37 | 35 | 14 | 8 |
| Dec 25 | 74 | 106 | +63.7% | 26 | 14 | 14 | 1 |
| Sep 25 | 54 | 55 | +0.9% | 14 | 8 | 14 | 2 |
| Jun 25 | 48 | 55 | +5.9% | 9 | 24 | 6 | 23 |
| Mar 25 | 47 | 51 | +2.8% | 9 | 19 | 3 | 2 |
| Dec 24 | 30 | 50 | +5721.0% | 7 | 22 | 0 | 3 |
| Sep 24 | 11 | 1 | +2.6% | 4 | 1 | 3 | 2 |
Inhibikase Therapeutics, Inc. — questions
- Who owns Inhibikase Therapeutics, Inc. stock?
- 106 institutions reported Inhibikase Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Sands Capital Alternatives, LLC (9.3%), Soleus Capital Management, L.P. (7.8%), Trails Edge Capital Partners, LP (6.5%).
- Are Inhibikase Therapeutics, Inc. insiders buying or selling?
- 1 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Inhibikase Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.